Even If Eli Lilly Stock Continues to Shine, Stay Away from This Pharmaceutical ETF

Barchart · 2026-06-02T19:02:50Z

Johnson & Johnson Hopes to Dethrone AbbVie's Biggest Growth Driver. Here's Why Investors Shouldn't Panic

Motley Fool · 2026-06-02T18:50:00Z

No Rate Cuts Until 2027? Grab These High-Yielding Safe Dividend Kings Now

24/7 Wall St. · 2026-06-01T12:20:04Z

Is It Too Late To Consider Johnson & Johnson (JNJ) After Its 48% One-Year Surge?

Simply Wall St. · 2026-06-01T07:11:30Z

Is Johnson & Johnson (JNJ) One of the Best Dividend Paying Stocks to Buy Right Now?

Insider Monkey · 2026-06-01T03:19:46Z

How to Build $12,500 a Month in Dividend Income From a $2.8 Million Portfolio Without Touching the Aggressive Tier

24/7 Wall St. · 2026-05-31T17:41:29Z

3 Dividend Kings That Earn Their Crown Every Quarter

MarketBeat · 2026-05-31T13:25:00Z

Nanobiotix Equity Raise Backs JNJ-1900 Progress And Volatile Share Rally

Simply Wall St. · 2026-05-30T22:04:06Z

How to Recession-Proof Your Retirement Income Before Summer 2026

Motley Fool · 2026-05-30T13:35:00Z

The Two Bucket Income Portfolio That Pays $5,000 a Month Plus a Cash Reserve to Survive 2008 Style Drawdowns

24/7 Wall St. · 2026-05-30T13:18:25Z